Results 211 to 220 of about 13,117,352 (339)

THE PROTEINS OF BLOOD AND SUBCUTANEOUS LYMPH IN DOGS [PDF]

, 1933
A. A. Weech, E. Goettsch, Edwina Reeves
openalex   +1 more source

Tumor clusters with divergent inflammation and human retroelement expression determine the clinical outcome of patients with serous ovarian cancer

Molecular Oncology, EarlyView.
Analysis of treatment‐naïve high‐grade serous ovarian carcinoma (HGSOC) and control tissues for ERVs, LINE‐1 (L1), inflammation, and immune checkpoints identified five clusters with diverse patient recurrence‐free survivals. An inflammation score was calculated and correlated with retroelement expression, where one novel cluster (Triple‐I) with high ...
Laura Glossner, Markus Eckstein, Christoph Mark, Matthias W. Beckmann, Arndt Hartmann, Pamela L. Strissel, Reiner Strick   +6 more
wiley   +1 more source

Diurnal rhythm of the human plasma proteome. [PDF]

Clin Proteomics
S Jóhönnuson EM, Sennels HP, Jørgensen HL, Hannibal J, Yeung CC, Rasmussen C, Prus GZ, Wewer Albrechtsen NJ, Nielsen AB.   +8 more
europepmc   +1 more source

A DIA‐MS‐based proteomics approach to find potential serum prognostic biomarkers in glioblastoma patients

Molecular Oncology, EarlyView.
A DIA‐MS‐based proteomics analysis of serum samples from GB patients and healthy controls showed that high levels of IL1R2 and low levels of CRTAC1 and HRG in serum are associated with poor survival outcomes for GB patients. These circulating proteins could serve as biomarkers for the prediction of outcome in patients with GB.
Anne Clavreul, François Guillonneau, Odile Blanchet, Hamza Lasla, Audrey Rousseau, Catherine Guette, Alice Boissard, Cécile Henry, Morgan Dhondt, Pascal Jézéquel, Philippe Menei, Jean‐Michel Lemée   +11 more
wiley   +1 more source

Identification of Cancer-Associated Proteins in Colorectal Cancer Using Mass Spectrometry. [PDF]

Proteomes
Toyota N, Konno R, Iwata S, Fujita S, Kodera Y, Noguchi R, Kondo T, Kawashima Y, Yoshimatsu Y.   +8 more
europepmc   +1 more source

EGFR‐STAT3 activation provides a therapeutic rationale for targeting aggressive ETV1‐positive prostate cancer

Molecular Oncology, EarlyView.
Cotargeting EGFR and STAT3 with Erlotinib and TTI‐101 impairs both 2D and 3D growth of ETV1‐overexpressing prostate cancer cells by disrupting a self‐sustaining ETV1–EGFR positive feedback loop that promotes EGFR and STAT3 expression and phosphorylation (activation).
Elsa Gomes Paiva, Bernardo Orr, Ana Azeredo, Andreia Brandão, Manuel R. Teixeira, Paula Paulo   +5 more
wiley   +1 more source

Mitochondrial proteins: Potential pathophysiological mechanisms of malignant progression in HCC. [PDF]

PLoS One
Liu Y, Shao Y, Zhu X, Shen Z, Bian Z.
europepmc   +1 more source

Evaluation and modification of tumor cell isolation techniques from malignant effusions for rapid drug sensitivity testing

Molecular Oncology, EarlyView.
Non‐small cell lung cancer targeted treatment is limited to a few known genetic alterations, with few alternatives in advanced treatment lines. To direct treatment decisions by drug sensitivity testing (DST), this study compared several methods for tumor cell isolation from malignant effusions, pointing to repeated CD45+ cell depletion for effective ...
Navit Mooshayef, Hana Barhom, Sumit Chatterji, Netta Hecht, Oran Warhaftig, Iris Kamer, Oranit Zadok, Jair Bar, Limor Broday, Amir Onn, Michael Peled   +10 more
wiley   +1 more source

Discovery of CRISPR-Cas12a clades using a large language model. [PDF]

Nat Commun
Feng Y, Shi J, Li Z, Li Y, Yang J, Huang S, Zheng J, Han W, Qiao Y, Zhang J, Liu Q, Yang Y, Hu C, Wu L, Zhang X, Tang J, Huang X, Ma P.   +17 more
europepmc   +1 more source

Tet Proteins Can Convert 5-Methylcytosine to 5-Formylcytosine and 5-Carboxylcytosine

Science, 2011
Shinsuke Ito, Li Shen, Qing Dai, Susan C. Wu, L. Collins, J. Swenberg, Chuan He, Yi Zhang   +7 more
semanticscholar   +1 more source